Nephrology · Transplant · Renal Nutrition
Partnering human beings
in their quest for healthy living.
Vyapitus Specialities is a private-limited Indian pharmaceutical company built around the management of challenging, chronic and difficult-to-treat diseases, with a deep focus on nephrology, solid organ transplantation, chronic kidney disease and renal nutrition.
A single therapeutic focus
The kidney - and the patients who live with it.
Why we exist
A kidney health emergency that needs serious medicine.
The companies that show up for India's kidney patients do not get to do everything. We chose to do only this - and to do it consistently, batch after batch, year after year.
138M
Indians estimated to live with chronic kidney disease - second-highest in the world.
GBD/Lancet, 2023
16.4%
Adult CKD prevalence (2018–2023), up from 11.1% in the previous period.
Talukdar et al., Nephrology 2025
18,900+
Solid organ transplants performed in India in 2024 - ranking third globally.
NOTTO, 2024
4.53L
Patients on dialysis under PMNDP in 2023–24, up from 2.43L four years earlier.
MoHFW, Feb 2025
Our Therapy Pillars
One focused portfolio. Five clinical pillars.
From the moment of transplant to the years of chronic disease management - we build the medicines a nephrology practice uses every day.
Transplant
Transplant Immunosuppression
Calcineurin inhibitors and antimetabolites - the backbone of long-term graft survival in solid-organ transplantation.
See the range →CKD Management
CKD - Metabolic & Bone Health
Enteric-coated sodium bicarbonate for metabolic acidosis, sevelamer carbonate for phosphate control - the day-to-day tools of CKD care.
See the range →Renal Nutrition
Renal Nutrition
Ketoanalogues for protein-restricted CKD diets, and CKD-tailored vitamin and iron support.
See the range →Hyperuricemia
Hyperuricemia & Gout in CKD
Febuxostat for the CKD population - without the HLA-B*5801 risk seen with allopurinol in Asian patients.
See the range →Gut–Kidney Axis
Gut–Kidney Axis
Renal-specific probiotic for the emerging gut–kidney axis in chronic kidney disease.
See the range →Our Brands
The molecules that keep kidneys working.
A pharmacology built around a single set of patients. Every brand below is sold under prescription by registered medical practitioners through licensed pharmacies.
CoverGraf®
Tacrolimus
0.5 mg hard gelatin capsule · 1 mg hard gelatin capsule
View product →
Mycodapt-S™
Mycophenolate Sodium
360 mg delayed-release tablet
View product →
Fosrego®
Sevelamer Carbonate
400 mg tablet · 800 mg tablet
View product →
Sobicoat®
Enteric-Coated Sodium Bicarbonate
500 mg enteric-coated tablet
View product →
Nuketo®
Alpha-Ketoanalogues of Essential Amino Acids
Tablet (standard strength)
View product →
Nixura®
Febuxostat
40 mg tablet · 80 mg tablet
View product →Innovation Hub
Why ketoanalogues matter: rethinking nutrition in pre-dialysis CKD.
Updated KDOQI 2020 guidelines and recent meta-analyses position a very-low-protein diet supplemented with ketoanalogues among the few interventions shown to slow CKD progression and delay dialysis initiation. We unpack the evidence, the dosing approach, and the practical pieces of running it in an Indian dietary context.
Read the long-form →Coming up on the Innovation Hub
- Tacrolimus trough-level variability and graft outcomes
- Sevelamer vs calcium-based binders: CV-calcification revisited
- Sodium bicarbonate in CKD: correcting metabolic acidosis
- The gut–kidney axis: rationale for probiotic adjuncts
Engage With Us
Four ways to start a conversation.
For Healthcare Professionals
Speak to our Medical Information team for clinical and prescribing questions.
Speak to us →For Patients & Caregivers
For any product-related question, please consult your treating physician. For non-clinical queries, write to us.
Contact us →Careers
A growing super-specialty pharmaceutical company. People who care about kidneys, find us.
See openings →Investors & Partners
Corporate information, governance, partnership and in-licensing enquiries.
Corporate information →